REVIEW article
Front. Microbiol.
Sec. Microorganisms in Vertebrate Digestive Systems
This article is part of the Research TopicPolyphenol-Microbiome Continuum: From Plant-Associated Microbes to Fermentation and Host HealthView all articles
Focus on Gut Microbiota Regulation: Exploring the Potential of Fermented Traditional Chinese Medicines in the Prevention and Treatment of Type 2 Diabetes Mellitus
Provisionally accepted
- Liaoning University of Traditional Chinese Medicine, Shenyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Type 2 diabetes mellitus (T2DM), a globally prevalent metabolic disorder, has dysbiosis of the gut microbiota as a significant pathogenic factor. Traditional Chinese medicine (TCM) fermentation, originating from traditional processing techniques, is a technology that combines modern microbiological methods with solid-state fermentation, submerged fermentation, and bidirectional fermentation of medicinal fungi. Under specific conditions, it facilitates the biotransformation of herbal raw materials, demonstrating distinct advantages in regulating gut microbiota. This study aims to outline the concept of fermented TCM, elucidate the relationship between gut microbiota and This is a provisional file, not the final typeset article T2DM, and explore the mechanisms by which fermented TCM modulates gut microbiota to improve T2DM. Literature searches in databases such as PubMed, Google Scholar, and Web of Science reveal that fermented TCM improves T2DM by targeting gut microbiota regulation as a core mechanism. The mechanisms may involve: Modulating gut microbiota composition (fermentation products increase beneficial bacteria abundance, decrease harmful bacteria proportion, and restore microbial balance); Influencing gut microbiota metabolites (promoting short-chain fatty acid (SCFA) production by microbiota, which participates in glucose and energy metabolism); Protecting intestinal barrier function (SCFAs enhance intestinal epithelial cell function, upregulate tight junction protein expression, preserve barrier integrity, and reduce endotoxin leakage into the bloodstream) and modulating intestinal immune function (inhibiting inflammatory responses, enhancing antioxidant activity, and regulating intestinal immune homeostasis). This study reviews the application research of fermented TCM in improving T2DM by regulating the gut microbiota, aiming to validate and reveal its potential in the prevention and treatment of T2DM through gut microbiota modulation.
Keywords: Gut Microbiota, novel technology, short-chain fatty acid, traditional Chinese medicine fermentation, type 2 diabetes mellitus
Received: 16 Dec 2025; Accepted: 26 Jan 2026.
Copyright: © 2026 Yang, Yang, Zhou, Shen, Shi and LIU. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ruodi Yang
Yan Shi
Juntong LIU
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.